Cefotaxime as the potential cause of transient acquired von Willebrand syndrome

    loading  Checking for direct PDF access through Ovid

Abstract

Acquired von Willebrand syndrome (AvWS) is a relatively rare bleeding disorder. It has been reported in association with myeloproliferative disorders, autoimmune diseases, plasma cell dyscrasias and certain drugs. Cefotaxime is a third generation cephalosporin widely used for surgical prophylaxis and as empirical treatment of bacterial meningitis. We report a case of a transient AvWS in association with cefotaxime therapy.

Related Topics

    loading  Loading Related Articles